scispace - formally typeset
N

Ni Shujun

Researcher at Zhejiang University

Publications -  7
Citations -  1640

Ni Shujun is an academic researcher from Zhejiang University. The author has contributed to research in topics: Drug resistance & Glycopeptide. The author has an hindex of 3, co-authored 7 publications receiving 1247 citations.

Papers
More filters
Journal ArticleDOI

Alterations of the human gut microbiome in liver cirrhosis

TL;DR: The gut microbiome in liver cirrhosis is characterized by comparing 98 patients and 83 healthy control individuals and on the basis of only 15 biomarkers, a highly accurate patient discrimination index is created and validated on an independent cohort, suggesting microbiota-targeted biomarkers may be a powerful tool for diagnosis of different diseases.
Journal ArticleDOI

Influence of H7N9 virus infection and associated treatment on human gut microbiota

TL;DR: It was concluded that H7N9 viral infection and antibiotic administration have a significant effect on the microbiota community with decreased diversity and overgrowth of the bacteria such as Escherichia coli and Enterococcus faecium.
Journal ArticleDOI

Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma.

TL;DR: The co-expression network analysis between DEGs and DELs showed that DELs were involved with metabolic, cell cycle, chemical carcinogenesis, and complement and coagulation cascade-related pathways and provide promising targets for the future diagnosis and treatment of HCC.
Patent

Method and kit for detecting drug resistance genes of ten trimethoprim drugs

TL;DR: In this paper, an amplification primer combination for specific amplification on the drug resistance genes of the ten trimethoprim drugs and a specific probe for detecting on the drugs resistant genes was presented.
Patent

Method of detecting drug resistance genes of 20 dfrA methoxy benzylamine pyrimidine drugs and kit used

TL;DR: In this paper, an amplification primer combination for detecting drug resistance genes of 20 dfrA methoxy benzylamine pyrimidine drugs was presented, and the method and the detection cost were also reduced greatly.